Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CHPA says keep drug, supplement AERs out ot CPSC database

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association argues OTC drug and dietary supplement adverse event reports should not be part of a safety incident database required by the Consumer Product Safety Improvement Act of 2008. In a July 20 letter to the Consumer Product Safety Commission, CHPA Associate General Counsel Alison Manhoff says the act exempts the type of food and drug products manufactured by CHPA members because they already are regulated by FDA. CPSC has regulatory authority over only food and drug products with packaging requirements covered in the Poison Prevention Packaging Act, Manhoff writes. Additionally, CHPA worries that consumers will be confused about where to report adverse events if PPPA products are included in CPSC's database. She explains that consumers may report incidents related to a drug or supplement to CPSC instead of FDA, thus delaying the possibility of a safety review. Manhoff writes "it is imperative that the commission provide sufficient instructions making it clear to the consumer that reports regarding the drug or dietary supplement itself should not be submitted to CPSC and must be reported directly to FDA and/or the manufacturer, as appropriate.
Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

PS104328

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel